We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. WASHINGTON — Patients with inflammatory arthritis who ...
People with lower interleukin-6 activity have a reduced risk of cardiovascular diseases, a new LMU study reveals. Lowering the activity of interleukin-6 (IL-6) - a key immune signal regulating ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Among targeted therapies, patients with VEXAS syndrome ...
CHICAGO -- Treatment of giant cell arteritis (GCA) with the oral drug upadacitinib (Rinvoq) was durably effective when continued for 2 years, results from a phase III trial extension indicated. Some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results